These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 9110097)

  • 21. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and classification of affective disorders: new insights from clinical and laboratory approaches.
    Akiskal HS
    Psychiatr Dev; 1983; 1(2):123-60. PubMed ID: 6371797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DST and TRH stimulation test in mood disorder subtypes.
    Levy AB; Stern SL
    Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtypes and laboratory measures of autonomous depression.
    Friedel RO
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):28-31. PubMed ID: 6807967
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological markers for endogenous depression in series and parallel.
    Feinberg M; Carroll BJ
    Biol Psychiatry; 1984 Jan; 19(1):3-11. PubMed ID: 6704459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone nonsuppression and short rapid eye movement latency in schizophrenia: markers of an affective diathesis?
    Goldman M; Tandon R; Taylor SF; DeQuardo JR; Shipley JE; Patel B; Reddig S; Jibson M
    Biol Psychiatry; 1996 Nov; 40(9):927-9. PubMed ID: 8896782
    [No Abstract]   [Full Text] [Related]  

  • 28. EEG studies of sleep in the diagnosis of depression.
    Feinberg M; Gillin JC; Carroll BJ; Greden JF; Zis AP
    Biol Psychiatry; 1982 Mar; 17(3):305-16. PubMed ID: 7082698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of low-dose dexamethasone on sleep EEG patterns, plasma cortisol, and the TSH response to TRH in major depression.
    Poland RE; McCracken JT; Lutchmansingh P; Tondo L
    Pharmacopsychiatry; 1993 May; 26(3):79-83. PubMed ID: 8415898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S
    Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool].
    Babinski T; Paunović VR
    Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R; Brown P; Bienenstock A; Mitton J
    Biol Psychiatry; 1984 Mar; 19(3):347-52. PubMed ID: 6426532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral ventricular size in major depressive disorder: association with delusional symptoms.
    Targum SD; Rosen LN; DeLisi LE; Weinberger DR; Citrin CM
    Biol Psychiatry; 1983 Mar; 18(3):329-36. PubMed ID: 6404312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder.
    Reist C; Kauffmann CD; Chicz-Demet A; Chen CC; Demet EM
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):433-43. PubMed ID: 7624494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 38. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
    Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ
    Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers of affective disorders and posttraumatic stress disorder: a pilot study with desipramine.
    Kauffman CD; Reist C; Djenderedjian A; Nelson JN; Haier RJ
    J Clin Psychiatry; 1987 Sep; 48(9):366-7. PubMed ID: 3114242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.